Chronic inflammatory skin diseases (CISD) represent a significant burden of skin disease in the United States, and a growing number of studies demonstrate that CISD are associated with multiple comorbidities. However, few studies examined multimorbidity in adults with CISD. We sought to determine whether hospitalized US adults with chronic inflammatory skin disorders have increased multi-morbidity and mortality risk. Data from the 2002–2012 Nationwide Inpatient Sample were analyzed, including a representative 20% sample of US hospitalizations. Charlson comorbidity index (CCI) and mean estimated 10-year survival were calculated. Multivariable linear regression models were constructed with CCI score and mean estimated 10-year survival as the dependent variables and chronic inflammatory skin diagnosis, age and sex as the independent variables. CCI scores were significantly higher in bullous pemphigoid (P = 0.0005) and dermatomyositis (P < 0.0001), lower in hidradenitis suppurativa (P < 0.0001), pemphigus (P < 0.0001), rosacea (P < 0.0001), and not significantly different in atopic dermatitis, alopecia areata, and lichen planus compared to psoriasis. Conversely, the mean estimated 10-year survival was higher in pemphigus (P = 0.0451), lichen planus (P = 0.0352), rosacea (P < 0.0001), lower in bullous pemphigoid and dermatomyositis (P < 0.0001), and similar in atopic dermatitis, alopecia areata, and hidradenitis suppurativa compared to psoriasis. Each CISD had a distinct profile of comorbidities when compared to psoriasis. Hospitalized adults with multiple CISD have increased multimorbidity and decreased 10-year survival. Further studies are needed to develop multidisciplinary strategies aimed at preventing and treating multimorbidity, especially modifiable cardiovascular factors in adults with CISD.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Data integrity statement
JI Silverberg had full access to all the data in the study and takes responsibility for the integrity of the data and accuracy of the data analysis. Study concept and design: JI Silverberg. Acquisition of Data: JI Silverberg, S Narla. Analysis and interpretation of data: S Narla, JI Silverberg, Drafting of the manuscript: S Narla, JI Silverberg. Critical revision of the manuscript for important intellectual content: S Narla, JI Silverberg. Statistical analysis: JI Silverberg, S Narla. Obtained funding: JI Silverberg. Administrative technical or material support: None. Study supervision: None. Financial disclosures: None. Design and conduct of the study? No. Collection, management, analysis and interpretation of data? No. Preparation, review, or approval of the manuscript? No. Decision to submit the manuscript for publication? No.
International Classification of Disease 9th edition Clinical Modification
Chronic obstructive pulmonary disease
Connective tissue disease
Acquired immunodeficiency syndrome
Chronic kidney disease
Transient ischemic attack
Congestive heart failure
Peptic ulcer disease
Nationwide inpatient sample
Charlson Comorbidity Index
Healthcare cost and utilization project
Agency for healthcare research and quality
Chronic inflammatory skin disease
Pefoyo AJK et al (2015) The increasing burden and complexity of multimorbidity. BMC Public Health 15:415–415
Organization WH (2014) Global status report on noncommunicable diseases 2014. WHO, Switzerland
van Oostrom SH et al (2012) Multimorbidity and comorbidity in the Dutch population—data from general practices. BMC Public Health 12(1):715
Barnett K et al (2012) Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet 380(9836):37–43
Wolff JL, Starfield B, Anderson G (2002) Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 162(20):2269–2276
Marengoni A et al (2011) Aging with multimorbidity: a systematic review of the literature. Ageing Res Rev 10(4):430–439
Willadsen TG et al (2018) Multimorbidity and mortality: a 15-year longitudinal registry-based nationwide Danish population study. J Comorbidity 8(1):2235042X18804063
Brunner PM et al (2017) Increasing comorbidities suggest that atopic dermatitis is a systemic disorder. J Investig Dermatol 137(1):18–25
Silverberg JI (2017) Selected comorbidities of atopic dermatitis: atopy, neuropsychiatric, and musculoskeletal disorders. Clin Dermatol 35(4):360–366
Silverberg JI et al (2018) Association of atopic dermatitis with allergic, autoimmune, and cardiovascular comorbidities in US adults. Ann Allergy Asthma Immunol 121(5):604 e3–612 e3
Narla S, Silverberg JI (2019) Association between atopic dermatitis and autoimmune disorders in US adults and children: a cross-sectional study. J Am Acad Dermatol 80(2):382–389
Andersen YMF et al (2017) Autoimmune diseases in adults with atopic dermatitis. J Am Acad Dermatol 76(2):274–280.e1
Mohan GC, Silverberg JI (2015) Association of vitiligo and alopecia areata with atopic dermatitis: a systematic review and meta-analysis. JAMA Dermatol 151(5):522–528
Rudwaleit M et al (2002) Atopic disorders in ankylosing spondylitis and rheumatoid arthritis. (Extended Report). Ann Rheum Dis 61:968
Schmitt J et al (2016) Atopic dermatitis is associated with an increased risk for rheumatoid arthritis and inflammatory bowel disease, and a decreased risk for type 1 diabetes. J Allergy Clin Immunol 137(1):130–136
Silverberg JI et al (2015) Sleep disturbances in adults with eczema are associated with impaired overall health: a US population-based study. J Investig Dermatol 135(1):56–66
Dreiher J, Weitzman D, Cohen AD (2009) Psoriasis and osteoporosis: a sex-specific association? J Investig Dermatol 129(7):1643–1649
Li X et al (2015) Association between psoriasis and chronic obstructive pulmonary disease: a systematic review and meta-analysis. PLoS ONE 10(12):e0145221
Ungprasert P, Srivali N, Thongprayoon C (2016) Association between psoriasis and chronic obstructive pulmonary disease: a systematic review and meta-analysis. J Dermatol Treat 27(4):316–321
Gelfand JM et al (2006) The risk of lymphoma in patients with psoriasis. J Investig Dermatol 126(10):2194–2201
Kwa MC, Silverberg JI (2017) Association between inflammatory skin disease and cardiovascular and cerebrovascular co-morbidities in US adults: analysis of nationwide inpatient sample data. Am J Clin Dermatol 18(6):813–823
Yeung H et al (2013) Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol 149(10):1173–1179
Miller IM, McAndrew RJ, Hamzavi I (2016) Prevalence, risk factors, and comorbidities of hidradenitis suppurativa. Dermatol Clin 34(1):7–16
Thyssen JP et al (2017) Assessment of major comorbidities in adults with atopic dermatitis using the Charlson comorbidity index. J Am Acad Dermatol 76(6):1088–1092.e1
Hsu DY et al (2017) Validation of international classification of disease ninth revision codes for atopic dermatitis. Allergy 72(7):1091–1095
Hsu D et al (2016) Validation of database search strategies for the epidemiological study of pemphigus and pemphigoid. Br J Dermatol 174(3):645–648
Kwa MC et al (2017) Validation of international classification of diseases codes for the epidemiologic study of dermatomyositis. Arthritis Care Res 69(5):753–757
Icen M et al (2008) Potential misclassification of patients with psoriasis in electronic databases. J Am Acad Dermatol 59(6):981–985
Asgari MM et al (2013) Validity of diagnostic codes and prevalence of psoriasis and psoriatic arthritis in a managed care population, 1996–2009. Pharmacoepidemiol Drug Saf 22(8):842–849
Kim GE, Shlyankevich J, Kimball AB (2014) The validity of the diagnostic code for hidradenitis suppurativa in an electronic database. Br J Dermatol 171(2):338–342
Susser SR, McCusker J, Belzile E (2008) Comorbidity information in older patients at an emergency visit: self-report vs. administrative data had poor agreement but similar predictive validity. J Clin Epidemiol 61(5):511–515
Librero J, Peiro S, Ordinana R (1999) Chronic comorbidity and outcomes of hospital care: length of stay, mortality, and readmission at 30 and 365 days. J Clin Epidemiol 52(3):171–179
Katz JN et al (1996) Can comorbidity be measured by questionnaire rather than medical record review? Med Care 34(1):73–84
Quan H et al (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43(11):1130–1139
Armstrong AW, Schupp C, Bebo B (2012) Psoriasis comorbidities: results from the national psoriasis foundation surveys 2003 to 2011. Dermatology 225(2):121–126
Elmets CA et al (2019) Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities. J Am Acad Dermatol 80(4):1073–1113
This publication was made possible with support from the Agency for Healthcare Research and Quality, grant number K12 HS023011, the Dermatology Foundation.
Conflict of interest
The authors declare that they have no competing interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
About this article
Cite this article
Narla, S., Silverberg, J.I. Multimorbidity and mortality risk in hospitalized adults with chronic inflammatory skin disease in the United States. Arch Dermatol Res 312, 507–512 (2020). https://doi.org/10.1007/s00403-020-02043-8
- Bullous pemphigoid
- Atopic dermatitis
- Hidradenitis suppurativa
- Lichen planus
- Alopecia areata
- Chronic inflammatory skin disease